Home>Research>Phase II study of anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer

US Oncology Research Publications

« Back to All Resources

Abstract
Cervical
Treatment

Phase II study of anti-PD-1 antibody balstilimab in patients with recurrent and/or metastatic cervical cancer